Yvonne Lee - All Headline News Staff Reporter

Baltimore, MD (AP) - Chinese health officials are partnering up with a U.S. institute to battle AIDS in a country that officials fear will see a tenfold increase in HIV infection over the next five years

A trial study is currently underway from Romark Laboratories to help victims of the vicious Chron's Disease.

Romark Laboratories has begun enrolling patients in a clinical trial evaluating Alinia (nitazoxanide) for treatment of mild to moderate active Crohn's disease in adults

A trial study is currently underway from Romark Laboratories to help victims of the vicious Chron's Disease.

Romark Laboratories has begun enrolling patients in a clinical trial evaluating Alinia (nitazoxanide) for treatment of mild to moderate active Crohn's disease in adults

Researchers at the University of Texas' Southwestern Medical Center have discovered a protein that is vital to the immune system's ability to fight off viral infections. They say their findings may lead to new therapies aimed at preventing and treating viral diseases such as the flu, hepatitis, West Nile virus, and SARS.

Dr. Zhijian "James" Chen unexpectedly found the protein in the membrane of an organelle called the mitochondrion

A new non-invasive early diagnosis of Alzheimer's disease has been developed by scientists at the Massachusetts Institute of Technology. The discovery of this non-invasive dye could aid in monitoring the progression of the disease and in studying the effectiveness of new treatments to stop it.

MIT, partnered with Massachusetts General Hospital and the University of Pittsburgh, have developed a contrast agent that would first bind to the protein deposits, or plaques, in the brain that cause Alzheimer's, and then fluoresce when exposed to radiation in the near-infrared range